**Author details**

Hanny Sawaf1 , Angelika L. Erwin2 , Fang Zhao3 , Tushar J. Vachharajani1 and Xiangling Wang1,2,4\*

1 Department of Kidney Medicine, Glickman Urology and Kidney Institute, Cleveland, Ohio, USA

2 Center for Personalized Genetic Healthcare, Cleveland Clinic Community Care and Population Health, Cleveland, Ohio, USA

3 Department of Pathology, The Center of Clinical Informatics Research and Education, Metrohealth System/Case Western Reserve University, Cleveland, Ohio, USA

4 Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA

\*Address all correspondence to: wangx8@ccf.org

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Enzyme-Replacement Therapy in Fabry Disease DOI: http://dx.doi.org/10.5772/intechopen.103799*
